Danone’s Lifeway purchase collapses (19459000)
Takeaways
- Danone North America retracted its bid to purchase Lifeway Foods, Inc., after due diligence, leading Lifeway to be uncertain about the leadership.
- Lifeway’s Board of Directors rejected Danone’s acquisition bids despite Danone as its biggest investor.
- There are internal family disputes and shareholder conflicts. Edward and Ludmila Smolyansky support Danone’s plans to takeover Lifeway and seek to replace the board of directors, which includes CEO Julie Smolyansky.
- Danone’s review of its investment options continues to determine whether it will support Edward Smolyansky as a board member.
- Danone’s decisions are likely to have an impact on the decision.
Danone North America has pulled out of the acquisition of Lifeway Foods, Inc., putting its leadership in doubt.
In August, the two companies entered into talks in secret after Lifeway’s Board rejected Danone’s two previous takeover bids.
Danone, Lifeway’s biggest investor, offered to buy the company’s shares in two separate transactions over the course of a year: $283m ($307m) and $283m ($307m). The two offers did not meet the board’s valuation for the Kefir Company, led by Julie Smolyansky.
Smolyansky has been criticized by Ludmila Smolyansky and Edward Smolyansky who are her longtime shareholders and support Danone’s plans to takeover the company. They want to replace Lifeway’s board, which includes Julie, as well as the CEO. To force their will, they launched an consent-solicitation process in July.
Danone, Lifeway and Edward sought to resolve the impasse again in this summer. The dairy giant flexed their muscles by signing the NDA. Should the talks fail again, they would support Edward’s proposal to replace Lifeway’s board. Danone (22,7%) and Edward and Ludmila (27.5%) hold together 50.1% Lifeway’s shares.
Danone retracted its purchase proposal on September 17 after doing due diligence.
In a filing with the SEC, the company stated that it was “in the process” of reviewing alternative investments in Lifeway. As part of the review of alternative investments in Lifeway we also consider whether we should vote our shares of Common Stock in support of Edward Smolyansky’s proposed consent solicitation to replace Lifeway’s entire Board of Directors. We haven’t yet reached a decision on this issue.
As part of the review process, we will take any actions we consider appropriate in relation to our Lifeway investment, such as, but not limited to, selling our entire investment or part thereof, holding our Lifeway investment or changing our intentions with regard to all of the matters mentioned in Item 4. of Schedule 13D.
Timeline
23 September 2024 Danone makes a cash bid for Lifeway Foods, Inc.’s shares worth $283m (approximately $25.00 per share). Edward Smolyansky who was in favor of the deal said that the bid represented a’substantial premium’ over Lifeway Foods’ recent share price.
5 November 2024 Lifeway rejects this bid because it is opportunistic.
15 November 2024 Danone North America submits a revised offer of approximately $307m (27 dollars per share, in cash).
The date is November 26th, 2024. Lifeway rejects Danone’s bid for the second time, saying that it represents a’very low multiple’ of 7 to 8.5 times expected EBITDA.
August 2, 2025 Edward and Ludmila smolyansky begin a process of consent seeking to remove Lifeway’s entire board.
August 5, 2025 Danone and Lifeway sign an NDA and return to the table to continue negotiations.
The date is September 17th, 2025. Danone pulls out of the talks after due diligence.
Lifeway said it is ‘firmly committed’ to driving shareholder value by executing its strategic plan, and exploring value-enhancing opportunities.
The stock of the company is down nearly 20% over the last five days after news broke that a third takeover attempt failed.
Lifeway Foods exceeded analyst expectations in Q2 2025 with a EPS surprise that was 3.7%, and revenue surprises of 7.8%.
The revenue increased by 18%, to $53.9m, driven by volume growth. EPS was $0.28, an increase from $0.26 vs YA. The gross profit margin has increased 160bps, or 28.6%. Net income is up to $4.2m from $3.8m in the previous year. Lifeway targets $45-50m of adjusted EBITDA in fiscal year 2027.
The company said that in the first two quarters of Q3 (up to August 31), Lifeway had recorded unaudited sales totaling $39.1m, which is a 20% increase over the previous year.
This year the brand has released an array of functional milk products, with its most recent offering being a line of functional drinks that contains protein, creatine, and probiotics.
The company plans to expand its manufacturing footprint by doubling its Waukesha capacity.
The question is: Will Julie Smolyansky continue to lead the company, or will a change of guard be inevitable? Danone may decide the outcome.